- call +1-201-465-4211
- email sales@marketquest.biz
- Call +1-201-465-4211
- Email: sales@marketquest.biz
The Oral Solid Dosage Contract Manufacturing market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest study, due to COVID-19 pandemic, the global Oral Solid Dosage Contract Manufacturing market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Specialty/Midsize accounting for % of the Oral Solid Dosage Contract Manufacturing global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Tablets segment is altered to a % CAGR between 2022 and 2028.
Global key companies of Oral Solid Dosage Contract Manufacturing include Catalent, DPx, Lonza Group (Capsugel), Piramal Pharma Solutions, and Aenova, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Oral Solid Dosage Contract Manufacturing market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Tablets
Capsules
Powders & Granules
Others
Market segment by Application, can be divided into
Specialty/Midsize
Generics
Big Pharma
Other
Market segment by players, this report covers
Catalent
DPx
Lonza Group (Capsugel)
Piramal Pharma Solutions
Aenova
Jubilant
Famar
Boehringer Ingelheim
Fareva Holding
AbbVie Contract Manufacturing
Nipro Pharma
Sopharma
Mylan (DPT Laboratories)
Recipharm
NextPharma
Dishman
Aesica Pharmaceuticals
CordenPharma
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Oral Solid Dosage Contract Manufacturing product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Oral Solid Dosage Contract Manufacturing, with revenue, gross margin and global market share of Oral Solid Dosage Contract Manufacturing from 2019 to 2022.
Chapter 3, the Oral Solid Dosage Contract Manufacturing competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Oral Solid Dosage Contract Manufacturing market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Oral Solid Dosage Contract Manufacturing research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Product Overview and Scope of Oral Solid Dosage Contract Manufacturing
1.2 Classification of Oral Solid Dosage Contract Manufacturing by Type
1.2.1 Overview: Global Oral Solid Dosage Contract Manufacturing Market Size by Type: 2017 Versus 2021 Versus 2028
1.2.2 Global Oral Solid Dosage Contract Manufacturing Revenue Market Share by Type in 2021
1.2.3 Tablets
1.2.4 Capsules
1.2.5 Powders & Granules
1.2.6 Others
1.3 Global Oral Solid Dosage Contract Manufacturing Market by Application
1.3.1 Overview: Global Oral Solid Dosage Contract Manufacturing Market Size by Application: 2017 Versus 2021 Versus 2028
1.3.2 Specialty/Midsize
1.3.3 Generics
1.3.4 Big Pharma
1.3.5 Other
1.4 Global Oral Solid Dosage Contract Manufacturing Market Size & Forecast
1.5 Global Oral Solid Dosage Contract Manufacturing Market Size and Forecast by Region
1.5.1 Global Oral Solid Dosage Contract Manufacturing Market Size by Region: 2017 VS 2021 VS 2028
1.5.2 Global Oral Solid Dosage Contract Manufacturing Market Size by Region, (2017-2022)
1.5.3 North America Oral Solid Dosage Contract Manufacturing Market Size and Prospect (2017-2028)
1.5.4 Europe Oral Solid Dosage Contract Manufacturing Market Size and Prospect (2017-2028)
1.5.5 Asia-Pacific Oral Solid Dosage Contract Manufacturing Market Size and Prospect (2017-2028)
1.5.6 South America Oral Solid Dosage Contract Manufacturing Market Size and Prospect (2017-2028)
1.5.7 Middle East and Africa Oral Solid Dosage Contract Manufacturing Market Size and Prospect (2017-2028)
1.6 Market Drivers, Restraints and Trends
1.6.1 Oral Solid Dosage Contract Manufacturing Market Drivers
1.6.2 Oral Solid Dosage Contract Manufacturing Market Restraints
1.6.3 Oral Solid Dosage Contract Manufacturing Trends Analysis
2 Company Profiles
2.1 Catalent
2.1.1 Catalent Details
2.1.2 Catalent Major Business
2.1.3 Catalent Oral Solid Dosage Contract Manufacturing Product and Solutions
2.1.4 Catalent Oral Solid Dosage Contract Manufacturing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.1.5 Catalent Recent Developments and Future Plans
2.2 DPx
2.2.1 DPx Details
2.2.2 DPx Major Business
2.2.3 DPx Oral Solid Dosage Contract Manufacturing Product and Solutions
2.2.4 DPx Oral Solid Dosage Contract Manufacturing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2.5 DPx Recent Developments and Future Plans
2.3 Lonza Group (Capsugel)
2.3.1 Lonza Group (Capsugel) Details
2.3.2 Lonza Group (Capsugel) Major Business
2.3.3 Lonza Group (Capsugel) Oral Solid Dosage Contract Manufacturing Product and Solutions
2.3.4 Lonza Group (Capsugel) Oral Solid Dosage Contract Manufacturing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3.5 Lonza Group (Capsugel) Recent Developments and Future Plans
2.4 Piramal Pharma Solutions
2.4.1 Piramal Pharma Solutions Details
2.4.2 Piramal Pharma Solutions Major Business
2.4.3 Piramal Pharma Solutions Oral Solid Dosage Contract Manufacturing Product and Solutions
2.4.4 Piramal Pharma Solutions Oral Solid Dosage Contract Manufacturing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4.5 Piramal Pharma Solutions Recent Developments and Future Plans
2.5 Aenova
2.5.1 Aenova Details
2.5.2 Aenova Major Business
2.5.3 Aenova Oral Solid Dosage Contract Manufacturing Product and Solutions
2.5.4 Aenova Oral Solid Dosage Contract Manufacturing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5.5 Aenova Recent Developments and Future Plans
2.6 Jubilant
2.6.1 Jubilant Details
2.6.2 Jubilant Major Business
2.6.3 Jubilant Oral Solid Dosage Contract Manufacturing Product and Solutions
2.6.4 Jubilant Oral Solid Dosage Contract Manufacturing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6.5 Jubilant Recent Developments and Future Plans
2.7 Famar
2.7.1 Famar Details
2.7.2 Famar Major Business
2.7.3 Famar Oral Solid Dosage Contract Manufacturing Product and Solutions
2.7.4 Famar Oral Solid Dosage Contract Manufacturing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7.5 Famar Recent Developments and Future Plans
2.8 Boehringer Ingelheim
2.8.1 Boehringer Ingelheim Details
2.8.2 Boehringer Ingelheim Major Business
2.8.3 Boehringer Ingelheim Oral Solid Dosage Contract Manufacturing Product and Solutions
2.8.4 Boehringer Ingelheim Oral Solid Dosage Contract Manufacturing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8.5 Boehringer Ingelheim Recent Developments and Future Plans
2.9 Fareva Holding
2.9.1 Fareva Holding Details
2.9.2 Fareva Holding Major Business
2.9.3 Fareva Holding Oral Solid Dosage Contract Manufacturing Product and Solutions
2.9.4 Fareva Holding Oral Solid Dosage Contract Manufacturing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9.5 Fareva Holding Recent Developments and Future Plans
2.10 AbbVie Contract Manufacturing
2.10.1 AbbVie Contract Manufacturing Details
2.10.2 AbbVie Contract Manufacturing Major Business
2.10.3 AbbVie Contract Manufacturing Oral Solid Dosage Contract Manufacturing Product and Solutions
2.10.4 AbbVie Contract Manufacturing Oral Solid Dosage Contract Manufacturing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10.5 AbbVie Contract Manufacturing Recent Developments and Future Plans
2.11 Nipro Pharma
2.11.1 Nipro Pharma Details
2.11.2 Nipro Pharma Major Business
2.11.3 Nipro Pharma Oral Solid Dosage Contract Manufacturing Product and Solutions
2.11.4 Nipro Pharma Oral Solid Dosage Contract Manufacturing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11.5 Nipro Pharma Recent Developments and Future Plans
2.12 Sopharma
2.12.1 Sopharma Details
2.12.2 Sopharma Major Business
2.12.3 Sopharma Oral Solid Dosage Contract Manufacturing Product and Solutions
2.12.4 Sopharma Oral Solid Dosage Contract Manufacturing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12.5 Sopharma Recent Developments and Future Plans
2.13 Mylan (DPT Laboratories)
2.13.1 Mylan (DPT Laboratories) Details
2.13.2 Mylan (DPT Laboratories) Major Business
2.13.3 Mylan (DPT Laboratories) Oral Solid Dosage Contract Manufacturing Product and Solutions
2.13.4 Mylan (DPT Laboratories) Oral Solid Dosage Contract Manufacturing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13.5 Mylan (DPT Laboratories) Recent Developments and Future Plans
2.14 Recipharm
2.14.1 Recipharm Details
2.14.2 Recipharm Major Business
2.14.3 Recipharm Oral Solid Dosage Contract Manufacturing Product and Solutions
2.14.4 Recipharm Oral Solid Dosage Contract Manufacturing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14.5 Recipharm Recent Developments and Future Plans
2.15 NextPharma
2.15.1 NextPharma Details
2.15.2 NextPharma Major Business
2.15.3 NextPharma Oral Solid Dosage Contract Manufacturing Product and Solutions
2.15.4 NextPharma Oral Solid Dosage Contract Manufacturing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.15.5 NextPharma Recent Developments and Future Plans
2.16 Dishman
2.16.1 Dishman Details
2.16.2 Dishman Major Business
2.16.3 Dishman Oral Solid Dosage Contract Manufacturing Product and Solutions
2.16.4 Dishman Oral Solid Dosage Contract Manufacturing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.16.5 Dishman Recent Developments and Future Plans
2.17 Aesica Pharmaceuticals
2.17.1 Aesica Pharmaceuticals Details
2.17.2 Aesica Pharmaceuticals Major Business
2.17.3 Aesica Pharmaceuticals Oral Solid Dosage Contract Manufacturing Product and Solutions
2.17.4 Aesica Pharmaceuticals Oral Solid Dosage Contract Manufacturing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.17.5 Aesica Pharmaceuticals Recent Developments and Future Plans
2.18 CordenPharma
2.18.1 CordenPharma Details
2.18.2 CordenPharma Major Business
2.18.3 CordenPharma Oral Solid Dosage Contract Manufacturing Product and Solutions
2.18.4 CordenPharma Oral Solid Dosage Contract Manufacturing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.18.5 CordenPharma Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Oral Solid Dosage Contract Manufacturing Revenue and Share by Players (2019, 2020, 2021, and 2022)
3.2 Market Concentration Rate
3.2.1 Top 3 Oral Solid Dosage Contract Manufacturing Players Market Share in 2021
3.2.2 Top 10 Oral Solid Dosage Contract Manufacturing Players Market Share in 2021
3.2.3 Market Competition Trend
3.3 Oral Solid Dosage Contract Manufacturing Players Head Office, Products and Services Provided
3.4 Oral Solid Dosage Contract Manufacturing Mergers & Acquisitions
3.5 Oral Solid Dosage Contract Manufacturing New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Oral Solid Dosage Contract Manufacturing Revenue and Market Share by Type (2017-2022)
4.2 Global Oral Solid Dosage Contract Manufacturing Market Forecast by Type (2023-2028)
5 Market Size Segment by Application
5.1 Global Oral Solid Dosage Contract Manufacturing Revenue Market Share by Application (2017-2022)
5.2 Global Oral Solid Dosage Contract Manufacturing Market Forecast by Application (2023-2028)
6 North America by Country, by Type, and by Application
6.1 North America Oral Solid Dosage Contract Manufacturing Revenue by Type (2017-2028)
6.2 North America Oral Solid Dosage Contract Manufacturing Revenue by Application (2017-2028)
6.3 North America Oral Solid Dosage Contract Manufacturing Market Size by Country
6.3.1 North America Oral Solid Dosage Contract Manufacturing Revenue by Country (2017-2028)
6.3.2 United States Oral Solid Dosage Contract Manufacturing Market Size and Forecast (2017-2028)
6.3.3 Canada Oral Solid Dosage Contract Manufacturing Market Size and Forecast (2017-2028)
6.3.4 Mexico Oral Solid Dosage Contract Manufacturing Market Size and Forecast (2017-2028)
7 Europe by Country, by Type, and by Application
7.1 Europe Oral Solid Dosage Contract Manufacturing Revenue by Type (2017-2028)
7.2 Europe Oral Solid Dosage Contract Manufacturing Revenue by Application (2017-2028)
7.3 Europe Oral Solid Dosage Contract Manufacturing Market Size by Country
7.3.1 Europe Oral Solid Dosage Contract Manufacturing Revenue by Country (2017-2028)
7.3.2 Germany Oral Solid Dosage Contract Manufacturing Market Size and Forecast (2017-2028)
7.3.3 France Oral Solid Dosage Contract Manufacturing Market Size and Forecast (2017-2028)
7.3.4 United Kingdom Oral Solid Dosage Contract Manufacturing Market Size and Forecast (2017-2028)
7.3.5 Russia Oral Solid Dosage Contract Manufacturing Market Size and Forecast (2017-2028)
7.3.6 Italy Oral Solid Dosage Contract Manufacturing Market Size and Forecast (2017-2028)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Oral Solid Dosage Contract Manufacturing Revenue by Type (2017-2028)
8.2 Asia-Pacific Oral Solid Dosage Contract Manufacturing Revenue by Application (2017-2028)
8.3 Asia-Pacific Oral Solid Dosage Contract Manufacturing Market Size by Region
8.3.1 Asia-Pacific Oral Solid Dosage Contract Manufacturing Revenue by Region (2017-2028)
8.3.2 China Oral Solid Dosage Contract Manufacturing Market Size and Forecast (2017-2028)
8.3.3 Japan Oral Solid Dosage Contract Manufacturing Market Size and Forecast (2017-2028)
8.3.4 South Korea Oral Solid Dosage Contract Manufacturing Market Size and Forecast (2017-2028)
8.3.5 India Oral Solid Dosage Contract Manufacturing Market Size and Forecast (2017-2028)
8.3.6 Southeast Asia Oral Solid Dosage Contract Manufacturing Market Size and Forecast (2017-2028)
8.3.7 Australia Oral Solid Dosage Contract Manufacturing Market Size and Forecast (2017-2028)
9 South America by Country, by Type, and by Application
9.1 South America Oral Solid Dosage Contract Manufacturing Revenue by Type (2017-2028)
9.2 South America Oral Solid Dosage Contract Manufacturing Revenue by Application (2017-2028)
9.3 South America Oral Solid Dosage Contract Manufacturing Market Size by Country
9.3.1 South America Oral Solid Dosage Contract Manufacturing Revenue by Country (2017-2028)
9.3.2 Brazil Oral Solid Dosage Contract Manufacturing Market Size and Forecast (2017-2028)
9.3.3 Argentina Oral Solid Dosage Contract Manufacturing Market Size and Forecast (2017-2028)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Oral Solid Dosage Contract Manufacturing Revenue by Type (2017-2028)
10.2 Middle East & Africa Oral Solid Dosage Contract Manufacturing Revenue by Application (2017-2028)
10.3 Middle East & Africa Oral Solid Dosage Contract Manufacturing Market Size by Country
10.3.1 Middle East & Africa Oral Solid Dosage Contract Manufacturing Revenue by Country (2017-2028)
10.3.2 Turkey Oral Solid Dosage Contract Manufacturing Market Size and Forecast (2017-2028)
10.3.3 Saudi Arabia Oral Solid Dosage Contract Manufacturing Market Size and Forecast (2017-2028)
10.3.4 UAE Oral Solid Dosage Contract Manufacturing Market Size and Forecast (2017-2028)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
List of Tables
Table 1. Global Oral Solid Dosage Contract Manufacturing Revenue by Type, (USD Million), 2017 VS 2021 VS 2028
Table 2. Global Oral Solid Dosage Contract Manufacturing Revenue by Application, (USD Million), 2017 VS 2021 VS 2028
Table 3. Global Market Oral Solid Dosage Contract Manufacturing Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)
Table 4. Global Oral Solid Dosage Contract Manufacturing Revenue (USD Million) by Region (2017-2022)
Table 5. Global Oral Solid Dosage Contract Manufacturing Revenue Market Share by Region (2023-2028)
Table 6. Catalent Corporate Information, Head Office, and Major Competitors
Table 7. Catalent Major Business
Table 8. Catalent Oral Solid Dosage Contract Manufacturing Product and Solutions
Table 9. Catalent Oral Solid Dosage Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 10. DPx Corporate Information, Head Office, and Major Competitors
Table 11. DPx Major Business
Table 12. DPx Oral Solid Dosage Contract Manufacturing Product and Solutions
Table 13. DPx Oral Solid Dosage Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 14. Lonza Group (Capsugel) Corporate Information, Head Office, and Major Competitors
Table 15. Lonza Group (Capsugel) Major Business
Table 16. Lonza Group (Capsugel) Oral Solid Dosage Contract Manufacturing Product and Solutions
Table 17. Lonza Group (Capsugel) Oral Solid Dosage Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 18. Piramal Pharma Solutions Corporate Information, Head Office, and Major Competitors
Table 19. Piramal Pharma Solutions Major Business
Table 20. Piramal Pharma Solutions Oral Solid Dosage Contract Manufacturing Product and Solutions
Table 21. Piramal Pharma Solutions Oral Solid Dosage Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 22. Aenova Corporate Information, Head Office, and Major Competitors
Table 23. Aenova Major Business
Table 24. Aenova Oral Solid Dosage Contract Manufacturing Product and Solutions
Table 25. Aenova Oral Solid Dosage Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 26. Jubilant Corporate Information, Head Office, and Major Competitors
Table 27. Jubilant Major Business
Table 28. Jubilant Oral Solid Dosage Contract Manufacturing Product and Solutions
Table 29. Jubilant Oral Solid Dosage Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 30. Famar Corporate Information, Head Office, and Major Competitors
Table 31. Famar Major Business
Table 32. Famar Oral Solid Dosage Contract Manufacturing Product and Solutions
Table 33. Famar Oral Solid Dosage Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 34. Boehringer Ingelheim Corporate Information, Head Office, and Major Competitors
Table 35. Boehringer Ingelheim Major Business
Table 36. Boehringer Ingelheim Oral Solid Dosage Contract Manufacturing Product and Solutions
Table 37. Boehringer Ingelheim Oral Solid Dosage Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 38. Fareva Holding Corporate Information, Head Office, and Major Competitors
Table 39. Fareva Holding Major Business
Table 40. Fareva Holding Oral Solid Dosage Contract Manufacturing Product and Solutions
Table 41. Fareva Holding Oral Solid Dosage Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 42. AbbVie Contract Manufacturing Corporate Information, Head Office, and Major Competitors
Table 43. AbbVie Contract Manufacturing Major Business
Table 44. AbbVie Contract Manufacturing Oral Solid Dosage Contract Manufacturing Product and Solutions
Table 45. AbbVie Contract Manufacturing Oral Solid Dosage Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 46. Nipro Pharma Corporate Information, Head Office, and Major Competitors
Table 47. Nipro Pharma Major Business
Table 48. Nipro Pharma Oral Solid Dosage Contract Manufacturing Product and Solutions
Table 49. Nipro Pharma Oral Solid Dosage Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 50. Sopharma Corporate Information, Head Office, and Major Competitors
Table 51. Sopharma Major Business
Table 52. Sopharma Oral Solid Dosage Contract Manufacturing Product and Solutions
Table 53. Sopharma Oral Solid Dosage Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 54. Mylan (DPT Laboratories) Corporate Information, Head Office, and Major Competitors
Table 55. Mylan (DPT Laboratories) Major Business
Table 56. Mylan (DPT Laboratories) Oral Solid Dosage Contract Manufacturing Product and Solutions
Table 57. Mylan (DPT Laboratories) Oral Solid Dosage Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 58. Recipharm Corporate Information, Head Office, and Major Competitors
Table 59. Recipharm Major Business
Table 60. Recipharm Oral Solid Dosage Contract Manufacturing Product and Solutions
Table 61. Recipharm Oral Solid Dosage Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 62. NextPharma Corporate Information, Head Office, and Major Competitors
Table 63. NextPharma Major Business
Table 64. NextPharma Oral Solid Dosage Contract Manufacturing Product and Solutions
Table 65. NextPharma Oral Solid Dosage Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 66. Dishman Corporate Information, Head Office, and Major Competitors
Table 67. Dishman Major Business
Table 68. Dishman Oral Solid Dosage Contract Manufacturing Product and Solutions
Table 69. Dishman Oral Solid Dosage Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 70. Aesica Pharmaceuticals Corporate Information, Head Office, and Major Competitors
Table 71. Aesica Pharmaceuticals Major Business
Table 72. Aesica Pharmaceuticals Oral Solid Dosage Contract Manufacturing Product and Solutions
Table 73. Aesica Pharmaceuticals Oral Solid Dosage Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 74. CordenPharma Corporate Information, Head Office, and Major Competitors
Table 75. CordenPharma Major Business
Table 76. CordenPharma Oral Solid Dosage Contract Manufacturing Product and Solutions
Table 77. CordenPharma Oral Solid Dosage Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 78. Global Oral Solid Dosage Contract Manufacturing Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)
Table 79. Global Oral Solid Dosage Contract Manufacturing Revenue Share by Players (2019, 2020, 2021, and 2022)
Table 80. Breakdown of Oral Solid Dosage Contract Manufacturing by Company Type (Tier 1, Tier 2 and Tier 3)
Table 81. Oral Solid Dosage Contract Manufacturing Players Head Office, Products and Services Provided
Table 82. Oral Solid Dosage Contract Manufacturing Mergers & Acquisitions in the Past Five Years
Table 83. Oral Solid Dosage Contract Manufacturing New Entrants and Expansion Plans
Table 84. Global Oral Solid Dosage Contract Manufacturing Revenue (USD Million) by Type (2017-2022)
Table 85. Global Oral Solid Dosage Contract Manufacturing Revenue Share by Type (2017-2022)
Table 86. Global Oral Solid Dosage Contract Manufacturing Revenue Forecast by Type (2023-2028)
Table 87. Global Oral Solid Dosage Contract Manufacturing Revenue by Application (2017-2022)
Table 88. Global Oral Solid Dosage Contract Manufacturing Revenue Forecast by Application (2023-2028)
Table 89. North America Oral Solid Dosage Contract Manufacturing Revenue by Type (2017-2022) & (USD Million)
Table 90. North America Oral Solid Dosage Contract Manufacturing Revenue by Type (2023-2028) & (USD Million)
Table 91. North America Oral Solid Dosage Contract Manufacturing Revenue by Application (2017-2022) & (USD Million)
Table 92. North America Oral Solid Dosage Contract Manufacturing Revenue by Application (2023-2028) & (USD Million)
Table 93. North America Oral Solid Dosage Contract Manufacturing Revenue by Country (2017-2022) & (USD Million)
Table 94. North America Oral Solid Dosage Contract Manufacturing Revenue by Country (2023-2028) & (USD Million)
Table 95. Europe Oral Solid Dosage Contract Manufacturing Revenue by Type (2017-2022) & (USD Million)
Table 96. Europe Oral Solid Dosage Contract Manufacturing Revenue by Type (2023-2028) & (USD Million)
Table 97. Europe Oral Solid Dosage Contract Manufacturing Revenue by Application (2017-2022) & (USD Million)
Table 98. Europe Oral Solid Dosage Contract Manufacturing Revenue by Application (2023-2028) & (USD Million)
Table 99. Europe Oral Solid Dosage Contract Manufacturing Revenue by Country (2017-2022) & (USD Million)
Table 100. Europe Oral Solid Dosage Contract Manufacturing Revenue by Country (2023-2028) & (USD Million)
Table 101. Asia-Pacific Oral Solid Dosage Contract Manufacturing Revenue by Type (2017-2022) & (USD Million)
Table 102. Asia-Pacific Oral Solid Dosage Contract Manufacturing Revenue by Type (2023-2028) & (USD Million)
Table 103. Asia-Pacific Oral Solid Dosage Contract Manufacturing Revenue by Application (2017-2022) & (USD Million)
Table 104. Asia-Pacific Oral Solid Dosage Contract Manufacturing Revenue by Application (2023-2028) & (USD Million)
Table 105. Asia-Pacific Oral Solid Dosage Contract Manufacturing Revenue by Region (2017-2022) & (USD Million)
Table 106. Asia-Pacific Oral Solid Dosage Contract Manufacturing Revenue by Region (2023-2028) & (USD Million)
Table 107. South America Oral Solid Dosage Contract Manufacturing Revenue by Type (2017-2022) & (USD Million)
Table 108. South America Oral Solid Dosage Contract Manufacturing Revenue by Type (2023-2028) & (USD Million)
Table 109. South America Oral Solid Dosage Contract Manufacturing Revenue by Application (2017-2022) & (USD Million)
Table 110. South America Oral Solid Dosage Contract Manufacturing Revenue by Application (2023-2028) & (USD Million)
Table 111. South America Oral Solid Dosage Contract Manufacturing Revenue by Country (2017-2022) & (USD Million)
Table 112. South America Oral Solid Dosage Contract Manufacturing Revenue by Country (2023-2028) & (USD Million)
Table 113. Middle East & Africa Oral Solid Dosage Contract Manufacturing Revenue by Type (2017-2022) & (USD Million)
Table 114. Middle East & Africa Oral Solid Dosage Contract Manufacturing Revenue by Type (2023-2028) & (USD Million)
Table 115. Middle East & Africa Oral Solid Dosage Contract Manufacturing Revenue by Application (2017-2022) & (USD Million)
Table 116. Middle East & Africa Oral Solid Dosage Contract Manufacturing Revenue by Application (2023-2028) & (USD Million)
Table 117. Middle East & Africa Oral Solid Dosage Contract Manufacturing Revenue by Country (2017-2022) & (USD Million)
Table 118. Middle East & Africa Oral Solid Dosage Contract Manufacturing Revenue by Country (2023-2028) & (USD Million)
List of Figures
Figure 1. Oral Solid Dosage Contract Manufacturing Picture
Figure 2. Global Oral Solid Dosage Contract Manufacturing Revenue Market Share by Type in 2021
Figure 3. Tablets
Figure 4. Capsules
Figure 5. Powders & Granules
Figure 6. Others
Figure 7. Oral Solid Dosage Contract Manufacturing Revenue Market Share by Application in 2021
Figure 8. Specialty/Midsize Picture
Figure 9. Generics Picture
Figure 10. Big Pharma Picture
Figure 11. Other Picture
Figure 12. Global Oral Solid Dosage Contract Manufacturing Market Size, (USD Million): 2017 VS 2021 VS 2028
Figure 13. Global Oral Solid Dosage Contract Manufacturing Revenue and Forecast (2017-2028) & (USD Million)
Figure 14. Global Oral Solid Dosage Contract Manufacturing Revenue Market Share by Region (2017-2028)
Figure 15. Global Oral Solid Dosage Contract Manufacturing Revenue Market Share by Region in 2021
Figure 16. North America Oral Solid Dosage Contract Manufacturing Revenue (USD Million) and Growth Rate (2017-2028)
Figure 17. Europe Oral Solid Dosage Contract Manufacturing Revenue (USD Million) and Growth Rate (2017-2028)
Figure 18. Asia-Pacific Oral Solid Dosage Contract Manufacturing Revenue (USD Million) and Growth Rate (2017-2028)
Figure 19. South America Oral Solid Dosage Contract Manufacturing Revenue (USD Million) and Growth Rate (2017-2028)
Figure 20. Middle East and Africa Oral Solid Dosage Contract Manufacturing Revenue (USD Million) and Growth Rate (2017-2028)
Figure 21. Oral Solid Dosage Contract Manufacturing Market Drivers
Figure 22. Oral Solid Dosage Contract Manufacturing Market Restraints
Figure 23. Oral Solid Dosage Contract Manufacturing Market Trends
Figure 24. Catalent Recent Developments and Future Plans
Figure 25. DPx Recent Developments and Future Plans
Figure 26. Lonza Group (Capsugel) Recent Developments and Future Plans
Figure 27. Piramal Pharma Solutions Recent Developments and Future Plans
Figure 28. Aenova Recent Developments and Future Plans
Figure 29. Jubilant Recent Developments and Future Plans
Figure 30. Famar Recent Developments and Future Plans
Figure 31. Boehringer Ingelheim Recent Developments and Future Plans
Figure 32. Fareva Holding Recent Developments and Future Plans
Figure 33. AbbVie Contract Manufacturing Recent Developments and Future Plans
Figure 34. Nipro Pharma Recent Developments and Future Plans
Figure 35. Sopharma Recent Developments and Future Plans
Figure 36. Mylan (DPT Laboratories) Recent Developments and Future Plans
Figure 37. Recipharm Recent Developments and Future Plans
Figure 38. NextPharma Recent Developments and Future Plans
Figure 39. Dishman Recent Developments and Future Plans
Figure 40. Aesica Pharmaceuticals Recent Developments and Future Plans
Figure 41. CordenPharma Recent Developments and Future Plans
Figure 42. Global Oral Solid Dosage Contract Manufacturing Revenue Share by Players in 2021
Figure 43. Oral Solid Dosage Contract Manufacturing Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021
Figure 44. Global Top 3 Players Oral Solid Dosage Contract Manufacturing Revenue Market Share in 2021
Figure 45. Global Top 10 Players Oral Solid Dosage Contract Manufacturing Revenue Market Share in 2021
Figure 46. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)
Figure 47. Global Oral Solid Dosage Contract Manufacturing Revenue Share by Type in 2021
Figure 48. Global Oral Solid Dosage Contract Manufacturing Market Share Forecast by Type (2023-2028)
Figure 49. Global Oral Solid Dosage Contract Manufacturing Revenue Share by Application in 2021
Figure 50. Global Oral Solid Dosage Contract Manufacturing Market Share Forecast by Application (2023-2028)
Figure 51. North America Oral Solid Dosage Contract Manufacturing Sales Market Share by Type (2017-2028)
Figure 52. North America Oral Solid Dosage Contract Manufacturing Sales Market Share by Application (2017-2028)
Figure 53. North America Oral Solid Dosage Contract Manufacturing Revenue Market Share by Country (2017-2028)
Figure 54. United States Oral Solid Dosage Contract Manufacturing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. Canada Oral Solid Dosage Contract Manufacturing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. Mexico Oral Solid Dosage Contract Manufacturing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Europe Oral Solid Dosage Contract Manufacturing Sales Market Share by Type (2017-2028)
Figure 58. Europe Oral Solid Dosage Contract Manufacturing Sales Market Share by Application (2017-2028)
Figure 59. Europe Oral Solid Dosage Contract Manufacturing Revenue Market Share by Country (2017-2028)
Figure 60. Germany Oral Solid Dosage Contract Manufacturing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. France Oral Solid Dosage Contract Manufacturing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. United Kingdom Oral Solid Dosage Contract Manufacturing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. Russia Oral Solid Dosage Contract Manufacturing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. Italy Oral Solid Dosage Contract Manufacturing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. Asia-Pacific Oral Solid Dosage Contract Manufacturing Sales Market Share by Type (2017-2028)
Figure 66. Asia-Pacific Oral Solid Dosage Contract Manufacturing Sales Market Share by Application (2017-2028)
Figure 67. Asia-Pacific Oral Solid Dosage Contract Manufacturing Revenue Market Share by Region (2017-2028)
Figure 68. China Oral Solid Dosage Contract Manufacturing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. Japan Oral Solid Dosage Contract Manufacturing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 70. South Korea Oral Solid Dosage Contract Manufacturing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 71. India Oral Solid Dosage Contract Manufacturing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 72. Southeast Asia Oral Solid Dosage Contract Manufacturing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Australia Oral Solid Dosage Contract Manufacturing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. South America Oral Solid Dosage Contract Manufacturing Sales Market Share by Type (2017-2028)
Figure 75. South America Oral Solid Dosage Contract Manufacturing Sales Market Share by Application (2017-2028)
Figure 76. South America Oral Solid Dosage Contract Manufacturing Revenue Market Share by Country (2017-2028)
Figure 77. Brazil Oral Solid Dosage Contract Manufacturing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. Argentina Oral Solid Dosage Contract Manufacturing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 79. Middle East and Africa Oral Solid Dosage Contract Manufacturing Sales Market Share by Type (2017-2028)
Figure 80. Middle East and Africa Oral Solid Dosage Contract Manufacturing Sales Market Share by Application (2017-2028)
Figure 81. Middle East and Africa Oral Solid Dosage Contract Manufacturing Revenue Market Share by Country (2017-2028)
Figure 82. Turkey Oral Solid Dosage Contract Manufacturing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 83. Saudi Arabia Oral Solid Dosage Contract Manufacturing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 84. UAE Oral Solid Dosage Contract Manufacturing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 85. Methodology
Figure 86. Research Process and Data Source
Please feel free to write an email to us or to use our electronic ticketing system.
